medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2011, Número S2

<< Anterior Siguiente >>

Ann Hepatol 2011; 10 (S2)


Nutritional support in the treatment of chronic hepatic encephalopathy

Milke GMP

Idioma: Ingles.
Referencias bibliográficas: 41
Paginas: 45-49
Archivo PDF: 71.39 Kb.


FRAGMENTO

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Guex E, Cheseaux M, Bertrand PC, Piquet MA, Bouvry S, Pilon N, et al. Prevalence of undernutrition in 143 patients before liver transplantation. The Lausanne experience between 1997 and 2005. Rev Med Suisse 2008; 4: 927-30.

  2. Italian Multicentre Cooperative Project on Nutrition in Liver Cirrhosis. Nutritional status in cirrhosis. J Hepatol 1994; 21: 317-25.

  3. Merli M, Riggio O, Dally L. Policentrica Italiana Nutrizione Cirrosi. Does malnutrition affect survival in cirrhosis? Hepatology 1995; 24: 1041-6.

  4. Zeman FJ. Liver disease and alcoholism. In: Zeman FJ (ed.). Clinical nutrition and dietetics. NY, USA: Macmillan; 1991, p. 517-53.

  5. Duarte RA, Estradas TJ, Torre A, Uribe M. Avances en la fisiopatología de la encefalopatía hepática. Medicas Dis 2007; 20: 195-202.

  6. Olde DSWM, Jalan R, Redhead DN, Hayes PC, Deutz NEP, Soeters PB. Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS. Hepatology 2002; 37: 1163-70.

  7. Merli M, Erikson SSL, Hagenfeldt H, Wahren J. Splanchnic and peripheral exchange of FFA in patients with liver cirrhosis. J Hepatol 1986; 3: 348-5.

  8. Fischer JE, Yoshimura N, Aguirre A, James JH, Cummings MG, Abel RM, Deindoerfer F. Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions. Am J Surg 1974; 127: 40-7.

  9. Soeters PB, Fischer JE. Insulin, glucagon and amino acid imbalance and hepatic encephalopathy. Lancet 1976; 2: 880-2.

  10. Mullen KD, Dasarathy S. Protein restriction in hepatic encephalopathy: necessary evil or illogical dogma? J Hepatol 2004; 41: 147-8.

  11. Plauth M, Merli M, Kondrup J. Management of hepatic encephalopathy. N Eng J Med 1997; 337: 1921-2.

  12. Swart GR, Van den Berg JWO, Wattimena JLD, Rietveld T, Van Vuure JK, Frenkel M. Elevated protein requirements in cirrhosis of the liver investigated by whole body protein turnover studies. Clin Sci 1988; 75: 101-7.

  13. Nielsen K, Kondrup J, Martinsen L, Dossing H, Larsson B, Stilling B, Jensen MG. Long-term oral refeeding of patients with cirrhosis of the liver. Br J Nutr 1995; 74: 557-67.

  14. Kondrup J, Nielsen K, Juul A. Effect of long-term refeeding on protein metabolism in patients with cirrhosis of the liver. Br J Nutr 1997; 77: 197-211.

  15. Merli M, Riggio O. Dietary and nutritional indications in hepatic encephalopathy. Metab Brain Dis 2009; 24: 211-21.

  16. Plauth M, Merli M, Kondrup J, Weimann A, Ferenti P, Muller MJ. ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr 1997; 16: 43-5.

  17. Mizock BA. Nutritional support in hepatic encephalopathy. Nutrition 1999; 15: 220-8.

  18. Blei AT, Córdoba J. Hepatic encephalopathy. Am J Gastroenterol 2001; 96: 1968-75.

  19. Córdoba J, López-Hellin J, Planas M, Sabin P, Sanpedro F, Castro F, et al. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol 2004; 41: 38-43.

  20. Hahn M, Massen O, Nencki M. Die Eck’s Fistel zwischen der unteren Holvene und der Pfortader und ihre Folgen fur den Organismus. Arch Exper Patol Pharmakol 1883; 13: 161–210.

  21. Balo J, Korpassy B. The encephalitis of the dog with Eck fistula fed on meat. Arch Pathol 1932; 13: 80-7.

  22. Sherlock S, Summerskill WHJ, White LP, Phear EA. Portalsystemic encephalopathy. Neurological complications of liver disease. Lancet 1954; 267: 454-7.

  23. Sherlock S. Hepatic encephalopathy. In: Diseases of the liver and biliary system. Oxford, UK: Blackwell; 1989: p. 109-10.

  24. Bianchi GP, Marchesini G, Fabbri A, Rondelli A, Bugianesi E, Zoli M, Pisi E. Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized cross-over comparison. J Intern Med 1993; 233: 385-92.

  25. Uribe M, Márquez MA, García RG, Ramos UMH, Vargas F, Villalobos A. Treatment of chronic portal-systemic encephalopathy with vegetable and animal protein diets. A controlled crossover study. Dig Dis Sci 1982; 27: 1109–16.

  26. Shaw S, Worner TM, Lieber CS. Comparison of animal and vegetable protein sources in the dietary management of hepatic encephalopathy. Am J Clin Nutr 1983; 38: 59-63.

  27. Chiarino C, Frosi A, Vezzoli F, Sforza M, Rusca M. Confroto tra una dieta a prevalente contenuto proteico vegetale ed una a prevalente contenuto proteico animale nella cirrosi epatica. Minerva Gastroenterol Dietol 1992; 38: 7-14.

  28. Uribe M, Dibildox M, Malpica S, Guillermo E, Villalobos A, Nieto L, et al. Beneficial effect of vegetable protein diet supplemented with Psyllium plantago in patients with hepatic encephalopathy and diabetes mellitus. Gastroenterology 1985; 88: 901-7.

  29. Gheorghe L, Jacob R, Vadan R, Jacob S, Gheorghe C. Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet. Rom J Gastroenterol 2005; 3: 231-8.

  30. Rudman D, Smith RB III, Salam AA, Warren D, Galambos JT, Wenger J. Ammonia content of food. Am J Clin Nutr 1973; 26: 487-90.

  31. Plauth M, Cabre E, Riggio O, Assis-Camilo M. Pirlich M, Kondrup J. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr 2006; 25: 285-94.

  32. Kondrup J. Nutrition in end stage liver disease. Best Pract Res Clin Gastroenterol 2006; 20: 547-60.

  33. Nakaya Y, Okita K, Suzuki K, et al. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 2007; 23: 113-20.

  34. Morgan TR, Moritz TE, Mendenhall CL, Haas R. Protein consumption and hepatic encephalopathy in alcoholic hepatitis. J Am Coll Nutr 1995; 2: 152-8.

  35. Shawcross D, Jalan R. Dispelling myths in the treatment of hepatic encephalopathy. Lancet 2005; 365: 431-3.

  36. Naylor CD, O’Rourke K, Detsky AS, Baker JP. Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy: a meta-analysis. Gastroenterology 1989; 97: 1033-8.

  37. Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C. Branched chain amino acids for hepatic encephalopathy (Cochrane Database Systematic Review). In: The Cochrane Library (Issue 2). Wiley, Chichester, UK; 2003.

  38. Marchesini G, Bianchi G, Merli M, Amodio P, Panella C, Loguercio C, et al. Nutritional supplementation with branchedchain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 2003; 124: 1792-801.

  39. Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005; 3: 705-13.

  40. León CDG. Comment on: Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial. Nutr Clin Pract 2009; 24: 104-6.

  41. Yamauchi M, Takeda K, Sakamoto K, Ohata M, Toda G. Effect of oral branched chain amino acid supplementation in the late evening on the nutritional state of patients with liver cirrhosis. Hepatol Res 2001; 21: 199-204.




2020     |     www.medigraphic.com